BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7503948)

  • 1. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
    von Asmuth EJ; Dentener MA; Bazil V; Bouma MG; Leeuwenberg JF; Buurman WA
    Immunology; 1993 Sep; 80(1):78-83. PubMed ID: 7503948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
    Couturier C; Jahns G; Kazatchkine MD; Haeffner-Cavaillon N
    Eur J Immunol; 1992 Jun; 22(6):1461-6. PubMed ID: 1376258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane.
    Sato TT; Kovacich JC; Boyle EM; Haddix TL; Weintraub A; Pohlman TH
    J Surg Res; 1998 Feb; 74(2):103-11. PubMed ID: 9587347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.
    Dentener MA; Bazil V; Von Asmuth EJ; Ceska M; Buurman WA
    J Immunol; 1993 Apr; 150(7):2885-91. PubMed ID: 7681082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.
    Issekutz AC; Lopes N
    Immunology; 1993 Aug; 79(4):600-7. PubMed ID: 8104889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.
    Labeta MO; Durieux JJ; Spagnoli G; Fernandez N; Wijdenes J; Herrmann R
    Immunology; 1993 Nov; 80(3):415-23. PubMed ID: 7507090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
    J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14.
    Pugin J; Ulevitch RJ; Tobias PS
    Prog Clin Biol Res; 1995; 392():369-73. PubMed ID: 8524944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages.
    Landmann R; Ludwig C; Obrist R; Obrecht JP
    J Cell Biochem; 1991 Dec; 47(4):317-29. PubMed ID: 1724447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipopolysaccharide and IL-1 but not of TNF-induced activation of human endothelial cells by suramin.
    Strassmann G; Graber N; Goyert SM; Fong M; McCullers S; Rong GW; Beall LD
    J Immunol; 1994 Sep; 153(5):2239-47. PubMed ID: 7519646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms.
    Loppnow H
    Prog Clin Biol Res; 1994; 388():309-21. PubMed ID: 7530369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by IL-4 and IL-10 of endotoxin-induced tissue factor activation in monocytic THP-1 cells: activating role of CD14 ligation.
    Chu AJ; Prasad JK
    J Surg Res; 1998 Nov; 80(1):80-7. PubMed ID: 9790819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS and cytokine-induced endothelial cell IL-6 release and ELAM-1 expression; involvement of serum.
    von Asmuth EJ; Leeuwenberg JF; Ceska M; Buurman WA
    Eur Cytokine Netw; 1991; 2(4):291-7. PubMed ID: 1721850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations.
    Pugin J; Ulevitch RJ; Tobias PS
    J Inflamm; 1995; 45(1):49-55. PubMed ID: 7583352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel surface molecule, RM3/1, that contributes to the adhesion of glucocorticoid-induced human monocytes to endothelial cells.
    Wenzel I; Roth J; Sorg C
    Eur J Immunol; 1996 Nov; 26(11):2758-63. PubMed ID: 8921966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE.
    Jabara HH; Vercelli D
    J Immunol; 1994 Aug; 153(3):972-8. PubMed ID: 7517978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.
    Gessani S; Testa U; Varano B; Di Marzio P; Borghi P; Conti L; Barberi T; Tritarelli E; Martucci R; Seripa D
    J Immunol; 1993 Oct; 151(7):3758-66. PubMed ID: 7690813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.
    Pedron T; Girard R; Chaby R
    J Immunol; 1995 Aug; 155(3):1460-71. PubMed ID: 7543522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of recombinant bovine CD14.
    Wang Y; Zarlenga DS; Paape MJ; Dahl GE; Tomita GM
    Vet Res; 2003; 34(4):413-21. PubMed ID: 12911858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
    Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
    J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.